surgeries and have reported our early findings.2 We extended our study to include animals for slaughter. As Drs McCarthy and Zumla refer to the organism being difficult to culture it is appropriate to present our methods, which by using a selective medium make the isolation and recognition of DF-2 organisms comparatively easy.
Cotton wool tipped swabs of incisor teeth and gingival margins were placed in Amies charcoal based transport medium for delivery to the laboratory, where they were cultured using brainheart infusion agar (Difco) containing horse blood 5%, cysteine hydrochloride 0 5 g/l, kanamycin 25 mg/l, and vancomycin 1 mg/l. Plates were incubated in 95% air and 5% carbon dioxide in 95% relative humidity at 37°C and examined after three and five days. Under these conditions DF-2 grew after three days as smooth grey convex, circular colonies about 2-3 mm in diameter. Gram stained smears showed pleomorphic Gram negati-ve bacilli with tapering ends, filamentous organisms being commonly seen. The identity of suspected isolates was confirmed using methods similar to those of Weaver et aP3 with the addition of rapid enzyme tests. In addition to organisms that conformed to previous descriptions of DF-2 others were isolated that fermented glucose, maltose, lactose, sucrose, and usually raffinose and inulin. They are thus similar to the DF-2 like strains reported by Weaver et al.4 Altogether 469 swabs were collected from dogs, cats, and other animals; the When the authors measured luteinising hormone concentrations during treatment they chose to analyse a single arbitrarily selected data point on each patient which may not be representative of the mean luteinising hormone concentration. From these data raised luteinising hormone concentrations may have an adverse ettect on ovulation and conception, given the limitations of a single sample per patient, but they do not show that raised luteinising hormone concentrations are a causal factor in early pregnancy loss. In the group in which luteinising hormone values were measured during the conception cycle the values in the group with early loss of pregnancy were the same as those in the group that proceeded to delivery. We do not wish to dismiss this attractive theory but would welcome more substantial evidence in its support. AUTHORS' REPLY, -As endocrinologists we cannot but accept the limitations of hormone measurements on isolated samples of biological material. None the less, the results in our paper that Drs Turner and White commented on may be more readily interpreted in the light of recent descriptions of the clinical presentation of patients with the polycystic ovary syndrome. For example, in a study of more than 500 patients with this condition 44% had a random serum luteinising hormone concentration that was raised, and infertility (but not hirsutism) was significantly more prevalent in these subjects than in those with normal luteinising hormone values (high v normal values: infertile 37% v 21%, x2=14 1, p=0 004).' Our paper was an attempt to determine the nature of this association of infertility with the hypersecretion of luteinising hormone. The results during treatment with pulsatile luteinising hormone releasing hormone, always reported as the mean of at least two measurements, were consistent with earlier studies both in experimental animals and in modern programmes of assisted fertility. We suggested that the hypersecretion of luteinising hormone exerts its adverse effect by causing premature completion of maturation of the oocyte contained in the follicle destined to ovulate. It is important, however, to recognise that luteinising hormone releasing hormone and its analogues may themselves have this effect.2 The situation is therefore potentially extremely complex in that both the condition and treatments commonly used to correct it may share a common and adverse pathway. This is a point that may need emphasis again when the results of treatments designed to inhibit luteinising hormone secretion are evaluated.
Finally, on a technical matter raised by Drs Turner and White the serum luteinising hormone measurements during treatment, rather than being arbitrarily timed, were specifically scheduled for the phase of maximum follicular growth, when the follicle wall is presumably most readily penetrated by luteinising hormone. Is there a genetic factor in flecainide toxicity? SIR, -Dr J Beckman and others' reported the risk of flecainide toxicity in poor metabolisers of sparteine. We report a further cause of flecainide toxicity in a neonate with Wolff-Parkinson-White syndrome that we believe was related to the method ofstorage ofhis oral flecainide preparation.
A 2940 g term boy was transferred to our unit aged 4 hours after developing a supraventricular tachycardia of 300 beats/min during the second stage of labour. This recurred after birth and was resistant to treatment with vagal stimulation, direct current shock, and intramuscular digoxin. On transfer he was found to have a narrow QRS tachycardia (of 270 beats/min) with a 1:1 atrioventricular relation. Facial immersion in ice cold water restored sinus rhythm, and the electrocardiogram then showed delta waves and a short PR interval confirming Wolff-Parkinson-White syndrome. The tachycardia recurred and was successfully treated with intravenous flecainide (2-5 mg). He was discharged after four days and was given oral flecainide syrup prepared by the hospital pharmacy (20 mg twice daily, 5 mg/ml). A trough plasma concentration with this regimen before discharge was 901 [ug/l (target range 400-1000 ig/l).
Nine days later he was reviewed on the ward. He was well but on examination had a slow irregular BMJ VOLUME 298
14 JANUARY 1989 pulse. An electrocardiogram showed sinus bradycardia with wide QRS complexes (132 ms) and a prolonged PR interval (188 ms) suggesting flecainide toxicity.2 There was no evidence of renal impairment. His parents had stored the flecainide syrup in their refrigerator, and, although they had seen "floaters" in the syrup, they had continued his treatment as instructed. Flecainide treatment was discontinued for six days and his electrocardiogram returned to normal. The same dose of oral flecainide (20 mg twice daily) was then restarted and was prepared as freshly reconstituted powders. He is now 3 months old and developing normally. He has continued to take oral flecainide powders and has had no recurrence of his tachycardia or electrocardiographic signs of flecainide toxicity.
We believe that the gross delay in atrial and ventricular conduction was due to the inadvertent administration of a toxic dose of flecainide syrup. This was caused by the storage of flecainide at 4°C, which in turn caused crystallisation of the drug into visible floaters of concentrated flecainide. When the crystals were ingested a toxic flecainide dose was received. We were able to confirm crystallisation of flecainide from syrup when it was refrigerated on the ward. We recommend that oral flecainide powders should be freshly reconstituted before each dose. BrMedJ 1988; 297:1047. (22 October.) From the other side of the fence SIR,-Dr Derek Woolffs Personal View' was timely as it reached me on the morning that my 10 week old daughter was discharged from our local hospital after having been admitted for a week for pneumonia. I found myself quite exhausted after a week as live in mother and 24 hour nurse and ill equipped to cope with my convalescent baby, a fractious toddler, my neglected husband, and the day to day running of our home.
However unremarkable illness might seem to the staff, admission of a child to hospital and the period of acute illness precipitates the parents and family into crisis. All the parents I met experienced a state of acute anxiety, which the staff failed either to recognise or to acknowledge. When an experienced general practitioner has taken some time and trouble at home to decide on hospital admission it is not reassuring to meet with inexplicable delays and to be left quite alone, literally holding the baby. The junior staff we met were by their own account overburdened and weary, and so it was not until a registrar was summoned that we obtained a considered opinion and appropriate investigation and treatment.
Most parents are acutely distressed by the physical state of their children and the intrusiveness of invasive procedures, so a ward design that forces all comers to pass the high dependency area where children were receiving chemotherapy was insensitive to all concerned. We found it unacceptable that babies were left to cry if the parent dared leave in search of a toilet, a telephone, a meal, or even an errant sibling. While I appreciate that staffing levels operate at a bare minimum, a portable baby alarm system could do much to allay parental anxieties.
In volunteering themselves as 24 hour nurses live in parents provide a continuity of care that is difficult to achieve with the vagaries of the nurses' shift system and the doctors' on call rota. We take on a responsible and stressful role, and we deserve some consideration and respect, or at least more practical help. 1988; 297:1417. (26 November.) Iron and folate supplements during pregnancy SIR,-We wish to add some observations to the debate on whether to give iron and folate supplements to pregnant women. ' We recently completed a study of 500 underprivileged women attending a satellite antenatal clinic in Glasgow. Altogether 115 women had reduced iron-stores (serum ferritin concentration <12 [tg/l) at their booking visit. A further 100 women had serum ferritin concentrations between 12 and 25 [tg/l and were considered to be potentially at risk of developing iron deficiency. Thirty one women were considered to be folate deficient (red cell folate <125 mg/l). All the patients were encouraged to take prophylactic doses of iron and folate.
Seventy nine per cent of women with reduced iron stores at the beginning of their pregnancy still had a serum ferritin concentration less than 12 tg/l at the time of delivery of their baby despite prophylaxis. At booking 12% had a haemoglobin concentration less than 110 g/l, and by term this proportion was 43%. Fifty six per cent ofthe at risk group had serum ferritin concentrations less than 12 [ig/l by delivery. At booking 6% of this group had a haemoglobin concentration less than 110 g/l. This number had risen to 33% by delivery. In contrast, folate deficiency developing during pregnancy occurred rarely (in less than 1%).
We suspect a low compliance rate with oral
